nodes	percent_of_prediction	percent_of_DWPC	metapath
Apixaban—ABCG2—Leflunomide—systemic lupus erythematosus	0.072	0.0908	CbGbCtD
Apixaban—ABCG2—Mycophenolate mofetil—systemic lupus erythematosus	0.0445	0.0561	CbGbCtD
Apixaban—ABCG2—Hydrocortisone—systemic lupus erythematosus	0.0357	0.045	CbGbCtD
Apixaban—ABCG2—Cyclosporine—systemic lupus erythematosus	0.0337	0.0425	CbGbCtD
Apixaban—CYP1A2—Leflunomide—systemic lupus erythematosus	0.0297	0.0374	CbGbCtD
Apixaban—CYP3A5—Dapsone—systemic lupus erythematosus	0.0284	0.0358	CbGbCtD
Apixaban—CYP2C8—Dapsone—systemic lupus erythematosus	0.0273	0.0344	CbGbCtD
Apixaban—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0267	0.0337	CbGbCtD
Apixaban—CYP3A5—Mycophenolate mofetil—systemic lupus erythematosus	0.0246	0.0311	CbGbCtD
Apixaban—CYP2C8—Mycophenolate mofetil—systemic lupus erythematosus	0.0237	0.0299	CbGbCtD
Apixaban—CYP2C19—Dapsone—systemic lupus erythematosus	0.0229	0.0289	CbGbCtD
Apixaban—ABCG2—Dexamethasone—systemic lupus erythematosus	0.0222	0.028	CbGbCtD
Apixaban—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0212	0.0267	CbGbCtD
Apixaban—CYP3A5—Hydrocortisone—systemic lupus erythematosus	0.0198	0.0249	CbGbCtD
Apixaban—CYP2C9—Dapsone—systemic lupus erythematosus	0.0191	0.024	CbGbCtD
Apixaban—CYP2C8—Hydrocortisone—systemic lupus erythematosus	0.019	0.024	CbGbCtD
Apixaban—CYP3A5—Cyclosporine—systemic lupus erythematosus	0.0187	0.0235	CbGbCtD
Apixaban—CYP2C8—Cyclosporine—systemic lupus erythematosus	0.018	0.0226	CbGbCtD
Apixaban—ABCG2—Methotrexate—systemic lupus erythematosus	0.0178	0.0225	CbGbCtD
Apixaban—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.016	0.0202	CbGbCtD
Apixaban—CYP2C19—Prednisone—systemic lupus erythematosus	0.0159	0.02	CbGbCtD
Apixaban—CYP2C19—Cyclosporine—systemic lupus erythematosus	0.0151	0.019	CbGbCtD
Apixaban—ABCB1—Betamethasone—systemic lupus erythematosus	0.0138	0.0173	CbGbCtD
Apixaban—ABCB1—Prednisolone—systemic lupus erythematosus	0.0136	0.0171	CbGbCtD
Apixaban—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.0129	0.0162	CbGbCtD
Apixaban—ABCB1—Prednisone—systemic lupus erythematosus	0.0128	0.0162	CbGbCtD
Apixaban—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0127	0.016	CbGbCtD
Apixaban—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.0125	0.0158	CbGbCtD
Apixaban—CYP2C9—cardial valve—systemic lupus erythematosus	0.0123	0.21	CbGeAlD
Apixaban—CYP3A5—Dexamethasone—systemic lupus erythematosus	0.0123	0.0155	CbGbCtD
Apixaban—ABCB1—Cyclosporine—systemic lupus erythematosus	0.0122	0.0153	CbGbCtD
Apixaban—CYP2C8—Dexamethasone—systemic lupus erythematosus	0.0118	0.0149	CbGbCtD
Apixaban—CYP3A4—Dapsone—systemic lupus erythematosus	0.0111	0.014	CbGbCtD
Apixaban—CYP2C19—Dexamethasone—systemic lupus erythematosus	0.00992	0.0125	CbGbCtD
Apixaban—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00961	0.0121	CbGbCtD
Apixaban—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00961	0.0121	CbGbCtD
Apixaban—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.00825	0.0104	CbGbCtD
Apixaban—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00824	0.0104	CbGbCtD
Apixaban—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00813	0.0103	CbGbCtD
Apixaban—ABCB1—Dexamethasone—systemic lupus erythematosus	0.008	0.0101	CbGbCtD
Apixaban—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00771	0.00972	CbGbCtD
Apixaban—CYP3A4—Prednisone—systemic lupus erythematosus	0.00768	0.00968	CbGbCtD
Apixaban—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00728	0.00918	CbGbCtD
Apixaban—ABCB1—Methotrexate—systemic lupus erythematosus	0.00643	0.00811	CbGbCtD
Apixaban—F10—blood plasma—systemic lupus erythematosus	0.00489	0.0831	CbGeAlD
Apixaban—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00479	0.00605	CbGbCtD
Apixaban—CYP2C19—urine—systemic lupus erythematosus	0.00343	0.0583	CbGeAlD
Apixaban—CYP1A2—urine—systemic lupus erythematosus	0.0028	0.0476	CbGeAlD
Apixaban—CYP2C9—urine—systemic lupus erythematosus	0.00266	0.0452	CbGeAlD
Apixaban—CYP2J2—nephron tubule—systemic lupus erythematosus	0.00207	0.0351	CbGeAlD
Apixaban—CYP3A4—urine—systemic lupus erythematosus	0.00203	0.0345	CbGeAlD
Apixaban—CYP2J2—skin of body—systemic lupus erythematosus	0.00193	0.0327	CbGeAlD
Apixaban—CYP2C19—blood plasma—systemic lupus erythematosus	0.00179	0.0304	CbGeAlD
Apixaban—F10—tendon—systemic lupus erythematosus	0.00179	0.0304	CbGeAlD
Apixaban—F10—lung—systemic lupus erythematosus	0.00157	0.0267	CbGeAlD
Apixaban—CYP2C8—blood plasma—systemic lupus erythematosus	0.00156	0.0266	CbGeAlD
Apixaban—CYP2J2—tendon—systemic lupus erythematosus	0.00147	0.0249	CbGeAlD
Apixaban—CYP1A2—blood plasma—systemic lupus erythematosus	0.00146	0.0249	CbGeAlD
Apixaban—CYP3A5—blood plasma—systemic lupus erythematosus	0.00141	0.024	CbGeAlD
Apixaban—CYP2C9—blood plasma—systemic lupus erythematosus	0.00139	0.0236	CbGeAlD
Apixaban—CYP2J2—lung—systemic lupus erythematosus	0.00129	0.0219	CbGeAlD
Apixaban—CYP2J2—nervous system—systemic lupus erythematosus	0.00119	0.0203	CbGeAlD
Apixaban—CYP2J2—central nervous system—systemic lupus erythematosus	0.00115	0.0195	CbGeAlD
Apixaban—CYP3A4—blood plasma—systemic lupus erythematosus	0.00106	0.018	CbGeAlD
Apixaban—F10—Beta2 integrin cell surface interactions—C3—systemic lupus erythematosus	0.000794	0.0126	CbGpPWpGaD
Apixaban—ABCG2—nephron tubule—systemic lupus erythematosus	0.000783	0.0133	CbGeAlD
Apixaban—ABCB1—blood plasma—systemic lupus erythematosus	0.000749	0.0127	CbGeAlD
Apixaban—CYP3A5—nephron tubule—systemic lupus erythematosus	0.000727	0.0124	CbGeAlD
Apixaban—F10—PTM: gamma carboxylation, hypusine formation and arylsulfatase activation—F2—systemic lupus erythematosus	0.000717	0.0114	CbGpPWpGaD
Apixaban—CYP2C8—kidney—systemic lupus erythematosus	0.000708	0.012	CbGeAlD
Apixaban—CYP3A5—kidney—systemic lupus erythematosus	0.000639	0.0109	CbGeAlD
Apixaban—CYP3A5—cortex of kidney—systemic lupus erythematosus	0.000622	0.0106	CbGeAlD
Apixaban—F10—Formation of Fibrin Clot (Clotting Cascade)—F2—systemic lupus erythematosus	0.000587	0.00931	CbGpPWpGaD
Apixaban—CYP2J2—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000561	0.00891	CbGpPWpGaD
Apixaban—ABCG2—bone marrow—systemic lupus erythematosus	0.000538	0.00915	CbGeAlD
Apixaban—ABCG2—HIF-2-alpha transcription factor network—ETS1—systemic lupus erythematosus	0.000504	0.008	CbGpPWpGaD
Apixaban—ABCG2—lung—systemic lupus erythematosus	0.000488	0.00829	CbGeAlD
Apixaban—CYP3A4—kidney—systemic lupus erythematosus	0.000479	0.00815	CbGeAlD
Apixaban—ABCB1—Allograft Rejection—IL21—systemic lupus erythematosus	0.000472	0.00749	CbGpPWpGaD
Apixaban—CYP1A2—lung—systemic lupus erythematosus	0.000469	0.00798	CbGeAlD
Apixaban—CYP2J2—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	0.000455	0.00722	CbGpPWpGaD
Apixaban—CYP3A5—lung—systemic lupus erythematosus	0.000453	0.0077	CbGeAlD
Apixaban—F10—Complement and Coagulation Cascades—C3—systemic lupus erythematosus	0.00045	0.00714	CbGpPWpGaD
Apixaban—CYP2J2—Biological oxidations—NAT2—systemic lupus erythematosus	0.000431	0.00684	CbGpPWpGaD
Apixaban—CYP2J2—Metapathway biotransformation—NAT2—systemic lupus erythematosus	0.000425	0.00675	CbGpPWpGaD
Apixaban—Diabetes mellitus—Triamcinolone—systemic lupus erythematosus	0.000425	0.00499	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Methylprednisolone—systemic lupus erythematosus	0.000424	0.00498	CcSEcCtD
Apixaban—Diabetes mellitus—Methylprednisolone—systemic lupus erythematosus	0.000424	0.00498	CcSEcCtD
Apixaban—Haemoglobin—Azathioprine—systemic lupus erythematosus	0.000421	0.00495	CcSEcCtD
Apixaban—Haematuria—Leflunomide—systemic lupus erythematosus	0.00042	0.00494	CcSEcCtD
Apixaban—Haemorrhage—Azathioprine—systemic lupus erythematosus	0.000419	0.00493	CcSEcCtD
Apixaban—Ecchymosis—Betamethasone—systemic lupus erythematosus	0.000418	0.00491	CcSEcCtD
Apixaban—Ecchymosis—Dexamethasone—systemic lupus erythematosus	0.000418	0.00491	CcSEcCtD
Apixaban—Hepatobiliary disease—Leflunomide—systemic lupus erythematosus	0.000417	0.0049	CcSEcCtD
Apixaban—Epistaxis—Leflunomide—systemic lupus erythematosus	0.000416	0.00489	CcSEcCtD
Apixaban—Petechiae—Methotrexate—systemic lupus erythematosus	0.000409	0.0048	CcSEcCtD
Apixaban—F10—Post-translational protein modification—MAN2A1—systemic lupus erythematosus	0.000404	0.00641	CbGpPWpGaD
Apixaban—Breast disorder—Cyclosporine—systemic lupus erythematosus	0.000399	0.00469	CcSEcCtD
Apixaban—Haemoglobin—Leflunomide—systemic lupus erythematosus	0.000398	0.00468	CcSEcCtD
Apixaban—Liver function test abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.000398	0.00467	CcSEcCtD
Apixaban—Haemorrhage—Leflunomide—systemic lupus erythematosus	0.000396	0.00465	CcSEcCtD
Apixaban—F10—Complement and Coagulation Cascades—F2—systemic lupus erythematosus	0.000395	0.00627	CbGpPWpGaD
Apixaban—Urinary tract disorder—Leflunomide—systemic lupus erythematosus	0.000391	0.00459	CcSEcCtD
Apixaban—Connective tissue disorder—Leflunomide—systemic lupus erythematosus	0.000389	0.00457	CcSEcCtD
Apixaban—Urethral disorder—Leflunomide—systemic lupus erythematosus	0.000388	0.00456	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000388	0.00456	CcSEcCtD
Apixaban—ABCB1—nephron tubule—systemic lupus erythematosus	0.000386	0.00657	CbGeAlD
Apixaban—Diabetes mellitus—Dexamethasone—systemic lupus erythematosus	0.000385	0.00453	CcSEcCtD
Apixaban—Diabetes mellitus—Betamethasone—systemic lupus erythematosus	0.000385	0.00453	CcSEcCtD
Apixaban—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—LYN—systemic lupus erythematosus	0.000384	0.00609	CbGpPWpGaD
Apixaban—Alanine aminotransferase increased—Mycophenolate mofetil—systemic lupus erythematosus	0.00038	0.00446	CcSEcCtD
Apixaban—Immune system disorder—Azathioprine—systemic lupus erythematosus	0.000379	0.00445	CcSEcCtD
Apixaban—Mediastinal disorder—Azathioprine—systemic lupus erythematosus	0.000378	0.00444	CcSEcCtD
Apixaban—Eye disorder—Leflunomide—systemic lupus erythematosus	0.00037	0.00435	CcSEcCtD
Apixaban—Ecchymosis—Prednisone—systemic lupus erythematosus	0.000364	0.00427	CcSEcCtD
Apixaban—Immune system disorder—Leflunomide—systemic lupus erythematosus	0.000357	0.0042	CcSEcCtD
Apixaban—Mediastinal disorder—Leflunomide—systemic lupus erythematosus	0.000357	0.00419	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Hydrocortisone—systemic lupus erythematosus	0.000346	0.00407	CcSEcCtD
Apixaban—ABCB1—kidney—systemic lupus erythematosus	0.000339	0.00577	CbGeAlD
Apixaban—Anaemia—Azathioprine—systemic lupus erythematosus	0.000337	0.00396	CcSEcCtD
Apixaban—Diabetes mellitus—Prednisone—systemic lupus erythematosus	0.000336	0.00395	CcSEcCtD
Apixaban—Breast disorder—Methylprednisolone—systemic lupus erythematosus	0.000333	0.00392	CcSEcCtD
Apixaban—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000331	0.00562	CbGeAlD
Apixaban—Melaena—Methotrexate—systemic lupus erythematosus	0.000328	0.00386	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Methylprednisolone—systemic lupus erythematosus	0.000325	0.00382	CcSEcCtD
Apixaban—Haematuria—Cyclosporine—systemic lupus erythematosus	0.000324	0.00381	CcSEcCtD
Apixaban—CYP2J2—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	0.000323	0.00512	CbGpPWpGaD
Apixaban—Hepatobiliary disease—Cyclosporine—systemic lupus erythematosus	0.000322	0.00378	CcSEcCtD
Apixaban—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—systemic lupus erythematosus	0.000321	0.0051	CbGpPWpGaD
Apixaban—Epistaxis—Cyclosporine—systemic lupus erythematosus	0.000321	0.00377	CcSEcCtD
Apixaban—Anaemia—Leflunomide—systemic lupus erythematosus	0.000318	0.00374	CcSEcCtD
Apixaban—Haematuria—Mycophenolate mofetil—systemic lupus erythematosus	0.000316	0.00372	CcSEcCtD
Apixaban—CYP3A4—Liver X Receptor Pathway—RXRA—systemic lupus erythematosus	0.000315	0.005	CbGpPWpGaD
Apixaban—CYP3A4—nervous system—systemic lupus erythematosus	0.000315	0.00535	CbGeAlD
Apixaban—Hepatobiliary disease—Mycophenolate mofetil—systemic lupus erythematosus	0.000314	0.00369	CcSEcCtD
Apixaban—Epistaxis—Mycophenolate mofetil—systemic lupus erythematosus	0.000313	0.00368	CcSEcCtD
Apixaban—Nausea—Dapsone—systemic lupus erythematosus	0.000313	0.00368	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic lupus erythematosus	0.000308	0.00363	CcSEcCtD
Apixaban—Haemoglobin—Cyclosporine—systemic lupus erythematosus	0.000307	0.00361	CcSEcCtD
Apixaban—Haemorrhage—Cyclosporine—systemic lupus erythematosus	0.000305	0.00359	CcSEcCtD
Apixaban—Ecchymosis—Methotrexate—systemic lupus erythematosus	0.000304	0.00357	CcSEcCtD
Apixaban—ABCB1—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.000303	0.00481	CbGpPWpGaD
Apixaban—CYP3A4—central nervous system—systemic lupus erythematosus	0.000303	0.00515	CbGeAlD
Apixaban—Urinary tract disorder—Cyclosporine—systemic lupus erythematosus	0.000302	0.00355	CcSEcCtD
Apixaban—Connective tissue disorder—Cyclosporine—systemic lupus erythematosus	0.0003	0.00353	CcSEcCtD
Apixaban—Haemoglobin—Mycophenolate mofetil—systemic lupus erythematosus	0.000299	0.00352	CcSEcCtD
Apixaban—Urethral disorder—Cyclosporine—systemic lupus erythematosus	0.000299	0.00352	CcSEcCtD
Apixaban—Haemorrhage—Mycophenolate mofetil—systemic lupus erythematosus	0.000298	0.0035	CcSEcCtD
Apixaban—ABCG2—HIF-1-alpha transcription factor network—ETS1—systemic lupus erythematosus	0.000297	0.0047	CbGpPWpGaD
Apixaban—Urinary tract disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000294	0.00346	CcSEcCtD
Apixaban—Connective tissue disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000293	0.00344	CcSEcCtD
Apixaban—Urethral disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000292	0.00343	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Prednisone—systemic lupus erythematosus	0.000292	0.00343	CcSEcCtD
Apixaban—Thrombocytopenia—Azathioprine—systemic lupus erythematosus	0.000292	0.00343	CcSEcCtD
Apixaban—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000292	0.00496	CbGeAlD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic lupus erythematosus	0.000291	0.00342	CcSEcCtD
Apixaban—Skin disorder—Azathioprine—systemic lupus erythematosus	0.000289	0.0034	CcSEcCtD
Apixaban—Anaphylactic shock—Leflunomide—systemic lupus erythematosus	0.000281	0.0033	CcSEcCtD
Apixaban—Diabetes mellitus—Methotrexate—systemic lupus erythematosus	0.000281	0.0033	CcSEcCtD
Apixaban—Haemoglobin—Prednisolone—systemic lupus erythematosus	0.000279	0.00328	CcSEcCtD
Apixaban—Eye disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000278	0.00327	CcSEcCtD
Apixaban—Hypotension—Azathioprine—systemic lupus erythematosus	0.000278	0.00327	CcSEcCtD
Apixaban—Haemorrhage—Prednisolone—systemic lupus erythematosus	0.000278	0.00327	CcSEcCtD
Apixaban—Angiopathy—Cyclosporine—systemic lupus erythematosus	0.000277	0.00326	CcSEcCtD
Apixaban—Nervous system disorder—Leflunomide—systemic lupus erythematosus	0.000276	0.00324	CcSEcCtD
Apixaban—Thrombocytopenia—Leflunomide—systemic lupus erythematosus	0.000275	0.00324	CcSEcCtD
Apixaban—Mediastinal disorder—Cyclosporine—systemic lupus erythematosus	0.000275	0.00324	CcSEcCtD
Apixaban—Skin disorder—Leflunomide—systemic lupus erythematosus	0.000273	0.00321	CcSEcCtD
Apixaban—Haemoglobin—Hydrocortisone—systemic lupus erythematosus	0.000273	0.00321	CcSEcCtD
Apixaban—Haemorrhage—Hydrocortisone—systemic lupus erythematosus	0.000271	0.00319	CcSEcCtD
Apixaban—Angiopathy—Mycophenolate mofetil—systemic lupus erythematosus	0.00027	0.00318	CcSEcCtD
Apixaban—Epistaxis—Triamcinolone—systemic lupus erythematosus	0.000269	0.00316	CcSEcCtD
Apixaban—Mediastinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000269	0.00316	CcSEcCtD
Apixaban—CYP3A5—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000268	0.00424	CbGpPWpGaD
Apixaban—Connective tissue disorder—Hydrocortisone—systemic lupus erythematosus	0.000267	0.00314	CcSEcCtD
Apixaban—ABCB1—bone marrow—systemic lupus erythematosus	0.000265	0.00451	CbGeAlD
Apixaban—Hypotension—Leflunomide—systemic lupus erythematosus	0.000263	0.00309	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Prednisone—systemic lupus erythematosus	0.000258	0.00303	CcSEcCtD
Apixaban—Gastrointestinal disorder—Azathioprine—systemic lupus erythematosus	0.000257	0.00302	CcSEcCtD
Apixaban—Haemoglobin—Triamcinolone—systemic lupus erythematosus	0.000257	0.00302	CcSEcCtD
Apixaban—Haemoglobin—Methylprednisolone—systemic lupus erythematosus	0.000256	0.00301	CcSEcCtD
Apixaban—Haemorrhage—Triamcinolone—systemic lupus erythematosus	0.000256	0.003	CcSEcCtD
Apixaban—Haemorrhage—Methylprednisolone—systemic lupus erythematosus	0.000255	0.003	CcSEcCtD
Apixaban—Eye disorder—Hydrocortisone—systemic lupus erythematosus	0.000254	0.00298	CcSEcCtD
Apixaban—Connective tissue disorder—Methylprednisolone—systemic lupus erythematosus	0.000251	0.00295	CcSEcCtD
Apixaban—Anaemia—Cyclosporine—systemic lupus erythematosus	0.000246	0.00289	CcSEcCtD
Apixaban—Immune system disorder—Hydrocortisone—systemic lupus erythematosus	0.000245	0.00288	CcSEcCtD
Apixaban—ABCG2—HIF-1-alpha transcription factor network—CXCL12—systemic lupus erythematosus	0.000243	0.00386	CbGpPWpGaD
Apixaban—Gastrointestinal disorder—Leflunomide—systemic lupus erythematosus	0.000243	0.00285	CcSEcCtD
Apixaban—CYP2J2—Biological oxidations—RXRA—systemic lupus erythematosus	0.000242	0.00383	CbGpPWpGaD
Apixaban—ABCB1—lung—systemic lupus erythematosus	0.00024	0.00409	CbGeAlD
Apixaban—Anaemia—Mycophenolate mofetil—systemic lupus erythematosus	0.00024	0.00282	CcSEcCtD
Apixaban—Eye disorder—Methylprednisolone—systemic lupus erythematosus	0.000238	0.0028	CcSEcCtD
Apixaban—Haemoglobin—Betamethasone—systemic lupus erythematosus	0.000233	0.00274	CcSEcCtD
Apixaban—Haemoglobin—Dexamethasone—systemic lupus erythematosus	0.000233	0.00274	CcSEcCtD
Apixaban—Syncope—Mycophenolate mofetil—systemic lupus erythematosus	0.000233	0.00273	CcSEcCtD
Apixaban—Haemorrhage—Betamethasone—systemic lupus erythematosus	0.000232	0.00273	CcSEcCtD
Apixaban—Haemorrhage—Dexamethasone—systemic lupus erythematosus	0.000232	0.00273	CcSEcCtD
Apixaban—Angiopathy—Methylprednisolone—systemic lupus erythematosus	0.000231	0.00272	CcSEcCtD
Apixaban—ABCB1—Allograft Rejection—C4A—systemic lupus erythematosus	0.000231	0.00366	CbGpPWpGaD
Apixaban—Immune system disorder—Methylprednisolone—systemic lupus erythematosus	0.00023	0.00271	CcSEcCtD
Apixaban—Mediastinal disorder—Methylprednisolone—systemic lupus erythematosus	0.00023	0.0027	CcSEcCtD
Apixaban—Loss of consciousness—Mycophenolate mofetil—systemic lupus erythematosus	0.000228	0.00268	CcSEcCtD
Apixaban—Liver function test abnormal—Methotrexate—systemic lupus erythematosus	0.000225	0.00265	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—systemic lupus erythematosus	0.000225	0.00264	CcSEcCtD
Apixaban—ABCB1—nervous system—systemic lupus erythematosus	0.000223	0.00379	CbGeAlD
Apixaban—Breast disorder—Methotrexate—systemic lupus erythematosus	0.000221	0.00259	CcSEcCtD
Apixaban—Hypersensitivity—Azathioprine—systemic lupus erythematosus	0.000219	0.00258	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic lupus erythematosus	0.000219	0.00258	CcSEcCtD
Apixaban—Anaphylactic shock—Cyclosporine—systemic lupus erythematosus	0.000217	0.00255	CcSEcCtD
Apixaban—Syncope—Prednisolone—systemic lupus erythematosus	0.000217	0.00255	CcSEcCtD
Apixaban—Eye disorder—Betamethasone—systemic lupus erythematosus	0.000217	0.00255	CcSEcCtD
Apixaban—Eye disorder—Dexamethasone—systemic lupus erythematosus	0.000217	0.00255	CcSEcCtD
Apixaban—ABCB1—central nervous system—systemic lupus erythematosus	0.000214	0.00365	CbGeAlD
Apixaban—Nervous system disorder—Cyclosporine—systemic lupus erythematosus	0.000213	0.0025	CcSEcCtD
Apixaban—Loss of consciousness—Prednisolone—systemic lupus erythematosus	0.000213	0.0025	CcSEcCtD
Apixaban—Thrombocytopenia—Cyclosporine—systemic lupus erythematosus	0.000212	0.0025	CcSEcCtD
Apixaban—Syncope—Hydrocortisone—systemic lupus erythematosus	0.000212	0.00249	CcSEcCtD
Apixaban—Anaphylactic shock—Mycophenolate mofetil—systemic lupus erythematosus	0.000212	0.00249	CcSEcCtD
Apixaban—Skin disorder—Cyclosporine—systemic lupus erythematosus	0.000211	0.00248	CcSEcCtD
Apixaban—Angiopathy—Betamethasone—systemic lupus erythematosus	0.00021	0.00247	CcSEcCtD
Apixaban—Angiopathy—Dexamethasone—systemic lupus erythematosus	0.00021	0.00247	CcSEcCtD
Apixaban—Shock—Mycophenolate mofetil—systemic lupus erythematosus	0.000208	0.00245	CcSEcCtD
Apixaban—Loss of consciousness—Hydrocortisone—systemic lupus erythematosus	0.000208	0.00244	CcSEcCtD
Apixaban—Nervous system disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000208	0.00244	CcSEcCtD
Apixaban—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—LYN—systemic lupus erythematosus	0.000207	0.00329	CbGpPWpGaD
Apixaban—F10—Hemostasis—ITGAX—systemic lupus erythematosus	0.000207	0.00329	CbGpPWpGaD
Apixaban—Thrombocytopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000207	0.00244	CcSEcCtD
Apixaban—Hypersensitivity—Leflunomide—systemic lupus erythematosus	0.000207	0.00243	CcSEcCtD
Apixaban—CYP2C19—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000207	0.00328	CbGpPWpGaD
Apixaban—Skin disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000206	0.00242	CcSEcCtD
Apixaban—F10—Hemostasis—F3—systemic lupus erythematosus	0.000204	0.00324	CbGpPWpGaD
Apixaban—Haemoglobin—Prednisone—systemic lupus erythematosus	0.000203	0.00239	CcSEcCtD
Apixaban—Haemorrhage—Prednisone—systemic lupus erythematosus	0.000202	0.00237	CcSEcCtD
Apixaban—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000202	0.0032	CbGpPWpGaD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—systemic lupus erythematosus	0.0002	0.00235	CcSEcCtD
Apixaban—Syncope—Triamcinolone—systemic lupus erythematosus	0.0002	0.00235	CcSEcCtD
Apixaban—Syncope—Methylprednisolone—systemic lupus erythematosus	0.000199	0.00234	CcSEcCtD
Apixaban—Connective tissue disorder—Prednisone—systemic lupus erythematosus	0.000198	0.00233	CcSEcCtD
Apixaban—Hypotension—Mycophenolate mofetil—systemic lupus erythematosus	0.000198	0.00232	CcSEcCtD
Apixaban—Anaphylactic shock—Prednisolone—systemic lupus erythematosus	0.000197	0.00232	CcSEcCtD
Apixaban—Dizziness—Azathioprine—systemic lupus erythematosus	0.000197	0.00231	CcSEcCtD
Apixaban—Loss of consciousness—Triamcinolone—systemic lupus erythematosus	0.000196	0.0023	CcSEcCtD
Apixaban—Loss of consciousness—Methylprednisolone—systemic lupus erythematosus	0.000195	0.00229	CcSEcCtD
Apixaban—Shock—Prednisolone—systemic lupus erythematosus	0.000194	0.00228	CcSEcCtD
Apixaban—Anaphylactic shock—Hydrocortisone—systemic lupus erythematosus	0.000193	0.00227	CcSEcCtD
Apixaban—F10—Metabolism of proteins—MAN2A1—systemic lupus erythematosus	0.000192	0.00304	CbGpPWpGaD
Apixaban—Shock—Hydrocortisone—systemic lupus erythematosus	0.00019	0.00223	CcSEcCtD
Apixaban—Nervous system disorder—Hydrocortisone—systemic lupus erythematosus	0.000189	0.00222	CcSEcCtD
Apixaban—Eye disorder—Prednisone—systemic lupus erythematosus	0.000189	0.00222	CcSEcCtD
Apixaban—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—systemic lupus erythematosus	0.000189	0.00299	CbGpPWpGaD
Apixaban—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000189	0.00299	CbGpPWpGaD
Apixaban—Rash—Azathioprine—systemic lupus erythematosus	0.000188	0.00221	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—systemic lupus erythematosus	0.000188	0.00221	CcSEcCtD
Apixaban—Dermatitis—Azathioprine—systemic lupus erythematosus	0.000188	0.0022	CcSEcCtD
Apixaban—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.000187	0.0022	CcSEcCtD
Apixaban—Skin disorder—Hydrocortisone—systemic lupus erythematosus	0.000187	0.0022	CcSEcCtD
Apixaban—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.000187	0.00296	CbGpPWpGaD
Apixaban—Dizziness—Leflunomide—systemic lupus erythematosus	0.000186	0.00219	CcSEcCtD
Apixaban—F10—Hemostasis—CLU—systemic lupus erythematosus	0.000185	0.00293	CbGpPWpGaD
Apixaban—Angiopathy—Prednisone—systemic lupus erythematosus	0.000183	0.00215	CcSEcCtD
Apixaban—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000183	0.00215	CcSEcCtD
Apixaban—Immune system disorder—Prednisone—systemic lupus erythematosus	0.000182	0.00214	CcSEcCtD
Apixaban—Anaphylactic shock—Triamcinolone—systemic lupus erythematosus	0.000182	0.00213	CcSEcCtD
Apixaban—Anaphylactic shock—Methylprednisolone—systemic lupus erythematosus	0.000181	0.00213	CcSEcCtD
Apixaban—Syncope—Betamethasone—systemic lupus erythematosus	0.000181	0.00213	CcSEcCtD
Apixaban—Syncope—Dexamethasone—systemic lupus erythematosus	0.000181	0.00213	CcSEcCtD
Apixaban—Hypotension—Hydrocortisone—systemic lupus erythematosus	0.00018	0.00212	CcSEcCtD
Apixaban—Haematuria—Methotrexate—systemic lupus erythematosus	0.000179	0.00211	CcSEcCtD
Apixaban—F10—Hemostasis—P2RY12—systemic lupus erythematosus	0.000179	0.00284	CbGpPWpGaD
Apixaban—Shock—Triamcinolone—systemic lupus erythematosus	0.000179	0.0021	CcSEcCtD
Apixaban—Shock—Methylprednisolone—systemic lupus erythematosus	0.000178	0.0021	CcSEcCtD
Apixaban—Hepatobiliary disease—Methotrexate—systemic lupus erythematosus	0.000178	0.00209	CcSEcCtD
Apixaban—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	0.000178	0.00209	CcSEcCtD
Apixaban—Loss of consciousness—Betamethasone—systemic lupus erythematosus	0.000177	0.00209	CcSEcCtD
Apixaban—Loss of consciousness—Dexamethasone—systemic lupus erythematosus	0.000177	0.00209	CcSEcCtD
Apixaban—Epistaxis—Methotrexate—systemic lupus erythematosus	0.000177	0.00208	CcSEcCtD
Apixaban—Rash—Leflunomide—systemic lupus erythematosus	0.000177	0.00208	CcSEcCtD
Apixaban—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000177	0.00208	CcSEcCtD
Apixaban—Nausea—Azathioprine—systemic lupus erythematosus	0.000177	0.00208	CcSEcCtD
Apixaban—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000176	0.00207	CcSEcCtD
Apixaban—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000174	0.00276	CbGpPWpGaD
Apixaban—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—systemic lupus erythematosus	0.000174	0.00276	CbGpPWpGaD
Apixaban—Haemoglobin—Methotrexate—systemic lupus erythematosus	0.00017	0.00199	CcSEcCtD
Apixaban—Hypotension—Methylprednisolone—systemic lupus erythematosus	0.000169	0.00199	CcSEcCtD
Apixaban—Haemorrhage—Methotrexate—systemic lupus erythematosus	0.000169	0.00198	CcSEcCtD
Apixaban—Nausea—Leflunomide—systemic lupus erythematosus	0.000167	0.00196	CcSEcCtD
Apixaban—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	0.000167	0.00196	CcSEcCtD
Apixaban—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000167	0.00196	CcSEcCtD
Apixaban—Urethral disorder—Methotrexate—systemic lupus erythematosus	0.000165	0.00194	CcSEcCtD
Apixaban—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	0.000165	0.00194	CcSEcCtD
Apixaban—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	0.000165	0.00194	CcSEcCtD
Apixaban—F10—Hemostasis—CSK—systemic lupus erythematosus	0.000165	0.00261	CbGpPWpGaD
Apixaban—F10—Hemostasis—SELE—systemic lupus erythematosus	0.000165	0.00261	CbGpPWpGaD
Apixaban—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000163	0.00258	CbGpPWpGaD
Apixaban—Anaemia—Prednisone—systemic lupus erythematosus	0.000163	0.00191	CcSEcCtD
Apixaban—Shock—Dexamethasone—systemic lupus erythematosus	0.000162	0.00191	CcSEcCtD
Apixaban—Shock—Betamethasone—systemic lupus erythematosus	0.000162	0.00191	CcSEcCtD
Apixaban—CYP3A5—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000162	0.00257	CbGpPWpGaD
Apixaban—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000162	0.0019	CcSEcCtD
Apixaban—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000162	0.0019	CcSEcCtD
Apixaban—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000161	0.0019	CcSEcCtD
Apixaban—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000161	0.0019	CcSEcCtD
Apixaban—ABCB1—Allograft Rejection—FOXP3—systemic lupus erythematosus	0.000161	0.00256	CbGpPWpGaD
Apixaban—ABCB1—HIF-1-alpha transcription factor network—ETS1—systemic lupus erythematosus	0.00016	0.00254	CbGpPWpGaD
Apixaban—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.00016	0.00188	CcSEcCtD
Apixaban—Eye disorder—Methotrexate—systemic lupus erythematosus	0.000158	0.00185	CcSEcCtD
Apixaban—Syncope—Prednisone—systemic lupus erythematosus	0.000158	0.00185	CcSEcCtD
Apixaban—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000156	0.00183	CcSEcCtD
Apixaban—F10—Hemostasis—ITGAM—systemic lupus erythematosus	0.000155	0.00246	CbGpPWpGaD
Apixaban—Loss of consciousness—Prednisone—systemic lupus erythematosus	0.000155	0.00182	CcSEcCtD
Apixaban—Hypotension—Betamethasone—systemic lupus erythematosus	0.000154	0.00181	CcSEcCtD
Apixaban—Hypotension—Dexamethasone—systemic lupus erythematosus	0.000154	0.00181	CcSEcCtD
Apixaban—Angiopathy—Methotrexate—systemic lupus erythematosus	0.000153	0.0018	CcSEcCtD
Apixaban—Immune system disorder—Methotrexate—systemic lupus erythematosus	0.000152	0.00179	CcSEcCtD
Apixaban—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.000152	0.00179	CcSEcCtD
Apixaban—F10—Hemostasis—LYN—systemic lupus erythematosus	0.00015	0.00237	CbGpPWpGaD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000149	0.00175	CcSEcCtD
Apixaban—ABCG2—HIF-2-alpha transcription factor network—EP300—systemic lupus erythematosus	0.000147	0.00233	CbGpPWpGaD
Apixaban—F10—Hemostasis—SH2B3—systemic lupus erythematosus	0.000147	0.00233	CbGpPWpGaD
Apixaban—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000145	0.00171	CcSEcCtD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—systemic lupus erythematosus	0.000145	0.0023	CbGpPWpGaD
Apixaban—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000144	0.00169	CcSEcCtD
Apixaban—Anaphylactic shock—Prednisone—systemic lupus erythematosus	0.000144	0.00169	CcSEcCtD
Apixaban—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000142	0.00167	CcSEcCtD
Apixaban—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000142	0.00167	CcSEcCtD
Apixaban—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000142	0.00167	CcSEcCtD
Apixaban—Shock—Prednisone—systemic lupus erythematosus	0.000141	0.00166	CcSEcCtD
Apixaban—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000141	0.00165	CcSEcCtD
Apixaban—CYP2C8—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.00014	0.00222	CbGpPWpGaD
Apixaban—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.00014	0.00165	CcSEcCtD
Apixaban—ABCG2—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.00014	0.00221	CbGpPWpGaD
Apixaban—Skin disorder—Prednisone—systemic lupus erythematosus	0.000139	0.00164	CcSEcCtD
Apixaban—ABCG2—HIF-2-alpha transcription factor network—VEGFA—systemic lupus erythematosus	0.000139	0.00221	CbGpPWpGaD
Apixaban—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000139	0.00221	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUNB—systemic lupus erythematosus	0.000138	0.00218	CbGpPWpGaD
Apixaban—Rash—Cyclosporine—systemic lupus erythematosus	0.000137	0.00161	CcSEcCtD
Apixaban—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000137	0.00161	CcSEcCtD
Apixaban—Anaemia—Methotrexate—systemic lupus erythematosus	0.000136	0.0016	CcSEcCtD
Apixaban—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000134	0.00157	CcSEcCtD
Apixaban—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000134	0.00157	CcSEcCtD
Apixaban—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000133	0.00157	CcSEcCtD
Apixaban—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000133	0.00157	CcSEcCtD
Apixaban—ABCB1—HIF-1-alpha transcription factor network—CXCL12—systemic lupus erythematosus	0.000132	0.00209	CbGpPWpGaD
Apixaban—CYP3A5—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	0.000131	0.00208	CbGpPWpGaD
Apixaban—Dizziness—Prednisolone—systemic lupus erythematosus	0.000131	0.00153	CcSEcCtD
Apixaban—Nausea—Cyclosporine—systemic lupus erythematosus	0.000129	0.00151	CcSEcCtD
Apixaban—CYP1A2—Phase II conjugation—NAT2—systemic lupus erythematosus	0.000128	0.00203	CbGpPWpGaD
Apixaban—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000128	0.0015	CcSEcCtD
Apixaban—ABCB1—Allograft Rejection—IL17A—systemic lupus erythematosus	0.000127	0.00201	CbGpPWpGaD
Apixaban—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000126	0.00148	CcSEcCtD
Apixaban—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000125	0.00198	CbGpPWpGaD
Apixaban—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—systemic lupus erythematosus	0.000125	0.00198	CbGpPWpGaD
Apixaban—Rash—Prednisolone—systemic lupus erythematosus	0.000125	0.00146	CcSEcCtD
Apixaban—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000124	0.00146	CcSEcCtD
Apixaban—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000124	0.00197	CbGpPWpGaD
Apixaban—CYP3A5—Biological oxidations—NAT2—systemic lupus erythematosus	0.000124	0.00197	CbGpPWpGaD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.000124	0.00146	CcSEcCtD
Apixaban—CYP3A5—Metapathway biotransformation—NAT2—systemic lupus erythematosus	0.000123	0.00194	CbGpPWpGaD
Apixaban—Rash—Hydrocortisone—systemic lupus erythematosus	0.000122	0.00143	CcSEcCtD
Apixaban—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000121	0.00143	CcSEcCtD
Apixaban—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.000121	0.00193	CbGpPWpGaD
Apixaban—Dizziness—Triamcinolone—systemic lupus erythematosus	0.00012	0.00141	CcSEcCtD
Apixaban—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	0.00012	0.00141	CcSEcCtD
Apixaban—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.00012	0.00141	CcSEcCtD
Apixaban—ABCB1—Allograft Rejection—IL12B—systemic lupus erythematosus	0.000118	0.00187	CbGpPWpGaD
Apixaban—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.000118	0.00138	CcSEcCtD
Apixaban—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	0.000117	0.00138	CcSEcCtD
Apixaban—F10—Post-translational protein modification—F2—systemic lupus erythematosus	0.000117	0.00186	CbGpPWpGaD
Apixaban—Nausea—Prednisolone—systemic lupus erythematosus	0.000117	0.00138	CcSEcCtD
Apixaban—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000116	0.00137	CcSEcCtD
Apixaban—F10—Hemostasis—IFNA1—systemic lupus erythematosus	0.000115	0.00183	CbGpPWpGaD
Apixaban—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000115	0.00135	CcSEcCtD
Apixaban—Rash—Triamcinolone—systemic lupus erythematosus	0.000115	0.00135	CcSEcCtD
Apixaban—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000114	0.00134	CcSEcCtD
Apixaban—Rash—Methylprednisolone—systemic lupus erythematosus	0.000114	0.00134	CcSEcCtD
Apixaban—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000114	0.00134	CcSEcCtD
Apixaban—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000114	0.00181	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—CXCL12—systemic lupus erythematosus	0.000114	0.00181	CbGpPWpGaD
Apixaban—CYP2C8—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	0.000114	0.0018	CbGpPWpGaD
Apixaban—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.000113	0.0018	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—CD40—systemic lupus erythematosus	0.000113	0.00179	CbGpPWpGaD
Apixaban—F10—Hemostasis—RASGRP1—systemic lupus erythematosus	0.000112	0.00178	CbGpPWpGaD
Apixaban—Hypotension—Methotrexate—systemic lupus erythematosus	0.000112	0.00132	CcSEcCtD
Apixaban—ABCB1—Allograft Rejection—CTLA4—systemic lupus erythematosus	0.000111	0.00176	CbGpPWpGaD
Apixaban—Dizziness—Betamethasone—systemic lupus erythematosus	0.000109	0.00128	CcSEcCtD
Apixaban—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000109	0.00128	CcSEcCtD
Apixaban—Nausea—Triamcinolone—systemic lupus erythematosus	0.000108	0.00127	CcSEcCtD
Apixaban—CYP2C8—Biological oxidations—NAT2—systemic lupus erythematosus	0.000108	0.00171	CbGpPWpGaD
Apixaban—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000108	0.00126	CcSEcCtD
Apixaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000107	0.0017	CbGpPWpGaD
Apixaban—CYP2C8—Metapathway biotransformation—NAT2—systemic lupus erythematosus	0.000106	0.00168	CbGpPWpGaD
Apixaban—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.000106	0.00124	CcSEcCtD
Apixaban—Rash—Dexamethasone—systemic lupus erythematosus	0.000104	0.00122	CcSEcCtD
Apixaban—Rash—Betamethasone—systemic lupus erythematosus	0.000104	0.00122	CcSEcCtD
Apixaban—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.000104	0.00122	CcSEcCtD
Apixaban—Dermatitis—Betamethasone—systemic lupus erythematosus	0.000104	0.00122	CcSEcCtD
Apixaban—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.000104	0.00122	CcSEcCtD
Apixaban—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	0.000101	0.00161	CbGpPWpGaD
Apixaban—Nausea—Betamethasone—systemic lupus erythematosus	9.79e-05	0.00115	CcSEcCtD
Apixaban—Nausea—Dexamethasone—systemic lupus erythematosus	9.79e-05	0.00115	CcSEcCtD
Apixaban—ABCB1—Allograft Rejection—HLA-DQA1—systemic lupus erythematosus	9.77e-05	0.00155	CbGpPWpGaD
Apixaban—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	9.75e-05	0.00155	CbGpPWpGaD
Apixaban—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	9.69e-05	0.00154	CbGpPWpGaD
Apixaban—CYP2C19—Biological oxidations—NAT2—systemic lupus erythematosus	9.61e-05	0.00152	CbGpPWpGaD
Apixaban—F10—Metabolism of proteins—ACE—systemic lupus erythematosus	9.51e-05	0.00151	CbGpPWpGaD
Apixaban—Dizziness—Prednisone—systemic lupus erythematosus	9.49e-05	0.00112	CcSEcCtD
Apixaban—CYP2C19—Metapathway biotransformation—NAT2—systemic lupus erythematosus	9.48e-05	0.0015	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	9.28e-05	0.00147	CbGpPWpGaD
Apixaban—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	9.25e-05	0.00147	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—HLA-DQB1—systemic lupus erythematosus	9.14e-05	0.00145	CbGpPWpGaD
Apixaban—Rash—Prednisone—systemic lupus erythematosus	9.05e-05	0.00106	CcSEcCtD
Apixaban—Dermatitis—Prednisone—systemic lupus erythematosus	9.04e-05	0.00106	CcSEcCtD
Apixaban—Hypersensitivity—Methotrexate—systemic lupus erythematosus	8.84e-05	0.00104	CcSEcCtD
Apixaban—CYP2C9—Biological oxidations—NAT2—systemic lupus erythematosus	8.76e-05	0.00139	CbGpPWpGaD
Apixaban—F10—Hemostasis—JAK1—systemic lupus erythematosus	8.71e-05	0.00138	CbGpPWpGaD
Apixaban—ABCG2—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	8.64e-05	0.00137	CbGpPWpGaD
Apixaban—CYP2C9—Metapathway biotransformation—NAT2—systemic lupus erythematosus	8.64e-05	0.00137	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—CD40LG—systemic lupus erythematosus	8.63e-05	0.00137	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—IL10—systemic lupus erythematosus	8.63e-05	0.00137	CbGpPWpGaD
Apixaban—Nausea—Prednisone—systemic lupus erythematosus	8.52e-05	0.001	CcSEcCtD
Apixaban—ABCB1—Allograft Rejection—IL4—systemic lupus erythematosus	8.4e-05	0.00133	CbGpPWpGaD
Apixaban—ABCG2—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	8.19e-05	0.0013	CbGpPWpGaD
Apixaban—F10—Hemostasis—IL2RA—systemic lupus erythematosus	8.13e-05	0.00129	CbGpPWpGaD
Apixaban—CYP2C8—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	8.05e-05	0.00128	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—FASLG—systemic lupus erythematosus	8.03e-05	0.00127	CbGpPWpGaD
Apixaban—Dizziness—Methotrexate—systemic lupus erythematosus	7.93e-05	0.000932	CcSEcCtD
Apixaban—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	7.9e-05	0.00125	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—FAS—systemic lupus erythematosus	7.74e-05	0.00123	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—IL2RA—systemic lupus erythematosus	7.69e-05	0.00122	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—C3—systemic lupus erythematosus	7.63e-05	0.00121	CbGpPWpGaD
Apixaban—Rash—Methotrexate—systemic lupus erythematosus	7.56e-05	0.000889	CcSEcCtD
Apixaban—Dermatitis—Methotrexate—systemic lupus erythematosus	7.55e-05	0.000888	CcSEcCtD
Apixaban—ABCB1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	7.54e-05	0.0012	CbGpPWpGaD
Apixaban—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	7.52e-05	0.00119	CbGpPWpGaD
Apixaban—CYP1A2—Biological oxidations—NAT2—systemic lupus erythematosus	7.49e-05	0.00119	CbGpPWpGaD
Apixaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	7.48e-05	0.00119	CbGpPWpGaD
Apixaban—CYP1A2—Metapathway biotransformation—NAT2—systemic lupus erythematosus	7.38e-05	0.00117	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—NAT2—systemic lupus erythematosus	7.38e-05	0.00117	CbGpPWpGaD
Apixaban—CYP2C19—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	7.19e-05	0.00114	CbGpPWpGaD
Apixaban—Nausea—Methotrexate—systemic lupus erythematosus	7.12e-05	0.000837	CcSEcCtD
Apixaban—F10—Hemostasis—F2—systemic lupus erythematosus	7.08e-05	0.00112	CbGpPWpGaD
Apixaban—CYP3A5—Biological oxidations—RXRA—systemic lupus erythematosus	6.97e-05	0.00111	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—HLA-DRB1—systemic lupus erythematosus	6.95e-05	0.0011	CbGpPWpGaD
Apixaban—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—systemic lupus erythematosus	6.75e-05	0.00107	CbGpPWpGaD
Apixaban—CYP2C9—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	6.56e-05	0.00104	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—CD80—systemic lupus erythematosus	6.42e-05	0.00102	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—systemic lupus erythematosus	6.25e-05	0.000991	CbGpPWpGaD
Apixaban—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	6.1e-05	0.000967	CbGpPWpGaD
Apixaban—CYP2C8—Biological oxidations—RXRA—systemic lupus erythematosus	6.04e-05	0.000957	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—systemic lupus erythematosus	5.99e-05	0.00095	CbGpPWpGaD
Apixaban—F10—Hemostasis—ALB—systemic lupus erythematosus	5.88e-05	0.000933	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.86e-05	0.00093	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	5.85e-05	0.000928	CbGpPWpGaD
Apixaban—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	5.78e-05	0.000917	CbGpPWpGaD
Apixaban—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	5.7e-05	0.000904	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—systemic lupus erythematosus	5.67e-05	0.0009	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	5.67e-05	0.0009	CbGpPWpGaD
Apixaban—F10—Hemostasis—NOS3—systemic lupus erythematosus	5.63e-05	0.000892	CbGpPWpGaD
Apixaban—CYP1A2—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	5.6e-05	0.000889	CbGpPWpGaD
Apixaban—F10—Metabolism of proteins—F2—systemic lupus erythematosus	5.57e-05	0.000884	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	5.55e-05	0.00088	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	5.52e-05	0.000875	CbGpPWpGaD
Apixaban—CYP2C19—Biological oxidations—RXRA—systemic lupus erythematosus	5.39e-05	0.000854	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	5.27e-05	0.000836	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	5.23e-05	0.00083	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—IFNG—systemic lupus erythematosus	5.08e-05	0.000805	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	4.98e-05	0.00079	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	4.98e-05	0.00079	CbGpPWpGaD
Apixaban—F10—Metabolism of proteins—CCL2—systemic lupus erythematosus	4.96e-05	0.000788	CbGpPWpGaD
Apixaban—CYP2C9—Biological oxidations—RXRA—systemic lupus erythematosus	4.91e-05	0.000779	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	4.84e-05	0.000767	CbGpPWpGaD
Apixaban—F10—Hemostasis—IL2—systemic lupus erythematosus	4.77e-05	0.000756	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	4.72e-05	0.000748	CbGpPWpGaD
Apixaban—ABCB1—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	4.67e-05	0.000741	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.61e-05	0.000731	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—IL2—systemic lupus erythematosus	4.51e-05	0.000715	CbGpPWpGaD
Apixaban—ABCB1—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	4.43e-05	0.000702	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	4.33e-05	0.000687	CbGpPWpGaD
Apixaban—F10—Hemostasis—EP300—systemic lupus erythematosus	4.28e-05	0.000679	CbGpPWpGaD
Apixaban—CYP1A2—Biological oxidations—RXRA—systemic lupus erythematosus	4.2e-05	0.000666	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—RXRA—systemic lupus erythematosus	4.13e-05	0.000656	CbGpPWpGaD
Apixaban—F10—Hemostasis—VEGFA—systemic lupus erythematosus	4.05e-05	0.000643	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	4.04e-05	0.000641	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	4.04e-05	0.000641	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	3.96e-05	0.000628	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.84e-05	0.000608	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—VEGFA—systemic lupus erythematosus	3.83e-05	0.000608	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	3.82e-05	0.000606	CbGpPWpGaD
Apixaban—F10—Hemostasis—TGFB1—systemic lupus erythematosus	3.72e-05	0.00059	CbGpPWpGaD
Apixaban—ABCG2—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	3.55e-05	0.000563	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—TGFB1—systemic lupus erythematosus	3.52e-05	0.000558	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—TNF—systemic lupus erythematosus	3.29e-05	0.000521	CbGpPWpGaD
Apixaban—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	3.24e-05	0.000514	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—NAT2—systemic lupus erythematosus	2.97e-05	0.000471	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PPARG—systemic lupus erythematosus	2.61e-05	0.000414	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	2.4e-05	0.000381	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—ALB—systemic lupus erythematosus	2.35e-05	0.000372	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.32e-05	0.000368	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	2.27e-05	0.000361	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—NOS3—systemic lupus erythematosus	2.25e-05	0.000356	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—NAT2—systemic lupus erythematosus	2.13e-05	0.000337	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	2.1e-05	0.000333	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.07e-05	0.000328	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PTGS2—systemic lupus erythematosus	2.05e-05	0.000326	CbGpPWpGaD
Apixaban—ABCG2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	2.02e-05	0.00032	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	2e-05	0.000317	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.92e-05	0.000305	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	1.89e-05	0.0003	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.89e-05	0.000299	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—NAT2—systemic lupus erythematosus	1.84e-05	0.000292	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.74e-05	0.000275	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—EP300—systemic lupus erythematosus	1.71e-05	0.000271	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—RXRA—systemic lupus erythematosus	1.66e-05	0.000264	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—NAT2—systemic lupus erythematosus	1.64e-05	0.000261	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.62e-05	0.000257	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.61e-05	0.000256	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	1.6e-05	0.000254	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	1.5e-05	0.000238	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.46e-05	0.000232	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.32e-05	0.000209	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.31e-05	0.000207	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—NAT2—systemic lupus erythematosus	1.28e-05	0.000203	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—RXRA—systemic lupus erythematosus	1.19e-05	0.000189	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.19e-05	0.000189	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.17e-05	0.000186	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.15e-05	0.000183	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.09e-05	0.000173	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.07e-05	0.00017	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PPARG—systemic lupus erythematosus	1.05e-05	0.000167	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—RXRA—systemic lupus erythematosus	1.03e-05	0.000164	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.03e-05	0.000163	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.02e-05	0.000161	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	9.88e-06	0.000157	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	9.57e-06	0.000152	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—ALB—systemic lupus erythematosus	9.44e-06	0.00015	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	9.37e-06	0.000149	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—RXRA—systemic lupus erythematosus	9.21e-06	0.000146	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	9.15e-06	0.000145	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—NOS3—systemic lupus erythematosus	9.03e-06	0.000143	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	8.99e-06	0.000143	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	8.55e-06	0.000136	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	8.4e-06	0.000133	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PTGS2—systemic lupus erythematosus	8.26e-06	0.000131	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	8.01e-06	0.000127	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	7.79e-06	0.000124	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PPARG—systemic lupus erythematosus	7.52e-06	0.000119	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	7.18e-06	0.000114	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—EP300—systemic lupus erythematosus	6.87e-06	0.000109	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ALB—systemic lupus erythematosus	6.77e-06	0.000107	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	6.66e-06	0.000106	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PPARG—systemic lupus erythematosus	6.52e-06	0.000103	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—NOS3—systemic lupus erythematosus	6.47e-06	0.000103	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PTGS2—systemic lupus erythematosus	5.92e-06	9.39e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ALB—systemic lupus erythematosus	5.86e-06	9.29e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PPARG—systemic lupus erythematosus	5.82e-06	9.23e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	5.68e-06	9.01e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—NOS3—systemic lupus erythematosus	5.61e-06	8.89e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	5.54e-06	8.79e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	5.3e-06	8.41e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ALB—systemic lupus erythematosus	5.23e-06	8.3e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PTGS2—systemic lupus erythematosus	5.13e-06	8.13e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ALB—systemic lupus erythematosus	5.11e-06	8.1e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—NOS3—systemic lupus erythematosus	5e-06	7.94e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—EP300—systemic lupus erythematosus	4.92e-06	7.81e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	4.88e-06	7.75e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	4.77e-06	7.56e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PTGS2—systemic lupus erythematosus	4.58e-06	7.26e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	4.56e-06	7.24e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	4.53e-06	7.19e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	4.47e-06	7.08e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—EP300—systemic lupus erythematosus	4.26e-06	6.76e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	4.17e-06	6.62e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	4.08e-06	6.46e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	3.9e-06	6.18e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—EP300—systemic lupus erythematosus	3.81e-06	6.04e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—EP300—systemic lupus erythematosus	3.71e-06	5.89e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	3.57e-06	5.66e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	3.5e-06	5.55e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	3.47e-06	5.5e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	3.15e-06	4.99e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	3.01e-06	4.77e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	2.97e-06	4.7e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	2.75e-06	4.36e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	2.29e-06	3.63e-05	CbGpPWpGaD
